首页 > 最新文献

Annals of vascular surgery最新文献

英文 中文
Do Not Mix It up! Long-Term Outcomes of Different Proximal Aortic Cuffs with the AFX Endograft 不要混淆!不同近端主动脉袖带与 AFX 内植物的长期疗效。
IF 1.4 4区 医学 Q3 PERIPHERAL VASCULAR DISEASE Pub Date : 2025-02-01 DOI: 10.1016/j.avsg.2024.10.024
Giulio Accarino , Aniello Enrico Puca , Antonia Rinaldi , Giovanni Fornino , Giancarlo Accarino , Davide Turchino , Raffaele Serra , Sergio Furgiuele , Carmine Vecchione , Umberto Marcello Bracale

Background

The AFX unibody endograft offers advantages in treating abdominal aortic aneurysms (AAAs) with narrow aortic bifurcations due to its unique design, where the flow divider sits at the native aortic bifurcation. However, its limited length options may limit complete proximal neck utilization. As per device instruction for use, the implant should be completed with an aortic cuff. This study aims to evaluate the long-term outcomes of patients treated with an all-Endologix implant versus a combination of Endologix and Medtronic devices.

Methods

This retrospective, single-center study included 134 consecutive AAA patients who underwent endovascular aneurysm repair (EVAR) using the AFX unibody endograft paired with suprarenal aortic cuffs from Endologix (n = 86) or Medtronic (n = 48) between November 2011 and November 2022. Patients were divided into 2 groups based on the type of aortic cuff used. The primary outcome was the occurrence of type 3A endoleaks at the longest available follow-up. Secondary outcomes included any endoleak, reintervention rates, all-cause mortality, and aneurysm-related death.

Results

The median follow-up was 41 months, and type 3A endoleaks occurred after a mean 34.8 months in 6 patients (4.5%), which is significantly more frequent in the mixed-device group (12.8%) (P < 0.001). Type 3A endoleak occurred regardless of overlap and developed over time. Endoleaks of any type were reported in 17 patients. Reinterventions were needed in 12 patients. The use of an Endurant cuff was associated with a significantly increased risk of type 3A endoleaks (hazard ratio [HR] 16.5; 95% [CI] 1.9–143; P = 0.011) and reinterventions (HR 9.67; 95% CI 1.9–49.6; P = 0.006).

Conclusions

Combining endografts from different manufacturers, especially those with differing materials and sealing mechanisms, may compromise the long-term integrity of certain EVAR repairs. Clinicians should exercise caution when considering mixed-device configurations and ensure rigorous follow-up for patients with such implants.
背景:AFX 一体式内植物移植因其独特的设计而在治疗主动脉分叉狭窄的腹主动脉瘤(AAA)方面具有优势,其分流器位于原生主动脉分叉处。不过,其有限的长度选择可能会限制近端颈部的完全利用。根据设备使用说明,植入时应使用主动脉袖带。本研究旨在评估采用全 Endologix 装置与 Endologix 和美敦力装置组合治疗患者的长期疗效:这项回顾性单中心研究纳入了 2011 年 11 月至 2022 年 11 月间连续接受血管内动脉瘤修补术(EVAR)的 134 例 AAA 患者,他们都使用了 AFX 一体式内植物和 Endologix(86 例)或 Medtronic(48 例)的肾上主动脉袖带。根据使用的主动脉袖带类型将患者分为两组。主要结果是在最长的随访时间内发生 3A 型内漏。次要结果包括任何内漏、再介入率、全因死亡率和动脉瘤相关死亡:中位随访时间为41个月,6名患者(4.5%)在平均34.8个月后发生3A型内膜渗漏,混合装置组的发生率明显更高(12.8%)(p结论:将不同制造商生产的内植物组合在一起,尤其是材料和密封机制不同的内植物,可能会损害某些 EVAR 修复术的长期完整性。临床医生在考虑混合装置配置时应谨慎行事,并确保对使用此类植入物的患者进行严格的随访。
{"title":"Do Not Mix It up! Long-Term Outcomes of Different Proximal Aortic Cuffs with the AFX Endograft","authors":"Giulio Accarino ,&nbsp;Aniello Enrico Puca ,&nbsp;Antonia Rinaldi ,&nbsp;Giovanni Fornino ,&nbsp;Giancarlo Accarino ,&nbsp;Davide Turchino ,&nbsp;Raffaele Serra ,&nbsp;Sergio Furgiuele ,&nbsp;Carmine Vecchione ,&nbsp;Umberto Marcello Bracale","doi":"10.1016/j.avsg.2024.10.024","DOIUrl":"10.1016/j.avsg.2024.10.024","url":null,"abstract":"<div><h3>Background</h3><div>The AFX unibody endograft offers advantages in treating abdominal aortic aneurysms (AAAs) with narrow aortic bifurcations due to its unique design, where the flow divider sits at the native aortic bifurcation. However, its limited length options may limit complete proximal neck utilization. As per device instruction for use, the implant should be completed with an aortic cuff. This study aims to evaluate the long-term outcomes of patients treated with an all-Endologix implant versus a combination of Endologix and Medtronic devices.</div></div><div><h3>Methods</h3><div>This retrospective, single-center study included 134 consecutive AAA patients who underwent endovascular aneurysm repair (EVAR) using the AFX unibody endograft paired with suprarenal aortic cuffs from Endologix (<em>n</em> = 86) or Medtronic (<em>n</em> = 48) between November 2011 and November 2022. Patients were divided into 2 groups based on the type of aortic cuff used. The primary outcome was the occurrence of type 3A endoleaks at the longest available follow-up. Secondary outcomes included any endoleak, reintervention rates, all-cause mortality, and aneurysm-related death.</div></div><div><h3>Results</h3><div>The median follow-up was 41 months, and type 3A endoleaks occurred after a mean 34.8 months in 6 patients (4.5%), which is significantly more frequent in the mixed-device group (12.8%) (<em>P</em> &lt; 0.001). Type 3A endoleak occurred regardless of overlap and developed over time. Endoleaks of any type were reported in 17 patients. Reinterventions were needed in 12 patients. The use of an Endurant cuff was associated with a significantly increased risk of type 3A endoleaks (hazard ratio [HR] 16.5; 95% [CI] 1.9–143; <em>P</em> = 0.011) and reinterventions (HR 9.67; 95% CI 1.9–49.6; <em>P</em> = 0.006).</div></div><div><h3>Conclusions</h3><div>Combining endografts from different manufacturers, especially those with differing materials and sealing mechanisms, may compromise the long-term integrity of certain EVAR repairs. Clinicians should exercise caution when considering mixed-device configurations and ensure rigorous follow-up for patients with such implants.</div></div>","PeriodicalId":8061,"journal":{"name":"Annals of vascular surgery","volume":"111 ","pages":"Pages 122-130"},"PeriodicalIF":1.4,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142708940","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Feasibility and Safety of Endovascular Interventions via Percutaneous Access to the Axillary Artery 经皮进入腋动脉进行血管内介入治疗的可行性和安全性。
IF 1.4 4区 医学 Q3 PERIPHERAL VASCULAR DISEASE Pub Date : 2025-02-01 DOI: 10.1016/j.avsg.2024.10.018
Caleb D. Alterman, Anton D. Perera, Prateek K. Gupta, Daniel M. Alterman

Background

Endovascular treatment of peripheral arterial disease requires safe and reliable arterial access. This study evaluates the feasibility and safety of percutaneous axillary artery access for endovascular therapy. A variety of anatomic and logistic obstacles can be overcome with upper extremity access. In this retrospective case review, we describe our experience with percutaneous trans-axillary access for lower extremity peripheral arterial disease intervention.

Methods

Medical records of all patients undergoing axillary artery percutaneous access from December 2021 to August 2024 were reviewed. Demographic data, procedural details, and complications such as pseudoaneurysm, hematoma, nerve injury, and closure device success were analyzed. Technical success and perioperative complications—including bruising, edema, hematoma, nerve injury, infection, thrombosis, and pseudoaneurysm—were assessed. Clinical outcomes were analyzed via follow-up clinic records.

Results

During the study period, 79 axillary artery accesses were performed on 64 patients. The patients were 55% male and had typical vascular comorbidities: hypertension (87%), hyperlipidemia (68%), coronary artery disease (27%), stroke (19%), and diabetes (16%); 58% were active tobacco users, and 80% were former tobacco users. Axillary access facilitated peripheral endovascular procedures, including iliac intervention (55), femoral (44), mesenteric (16), tibial (11), and embolization or visceral aneurysm treatments. A 6F sheath and ultrasound-guided Angio-Seal closure device were uniformly employed, with no major complications, perioperative deaths, or reoperations required. Minor complications of bruising and edema were present in 11 patients (14%). Other minor complications such as hematoma, nerve injury, thrombosis, dissection, pseudoaneurysm, or limb ischemia were absent.

Conclusions

Percutaneous axillary artery access demonstrates promise for complex endovascular interventions with a favorable safety profile. Advantages include avoidance of unfavorable femoral anatomy, improved working length compared with radial access, and enhanced control of visceral therapy. Bilateral iliac and lower extremity therapy is feasible in a single treatment as well. Percutaneous axillary artery access is a safe, reliable adjunct for enhancing endovascular arterial intervention capabilities.
目的:外周动脉疾病的血管内治疗需要安全可靠的动脉通路。本研究评估了经皮腋动脉入路进行血管内治疗的可行性和安全性。上肢入路可以克服各种解剖和后勤障碍。在这篇回顾性病例回顾中,我们介绍了经皮经腋动脉入路进行下肢外周动脉疾病介入治疗的经验:方法:回顾 2021 年 12 月至 2024 年 8 月期间所有接受腋动脉经皮入路手术患者的病历。分析了人口统计学数据、手术细节以及假性动脉瘤、血肿、神经损伤和闭合装置成功率等并发症。评估了技术成功率和围手术期并发症,包括瘀伤、水肿、血肿、神经损伤、感染、血栓形成和假性动脉瘤。临床结果通过随访门诊记录进行分析:研究期间,共为 64 名患者实施了 79 例腋窝动脉入路手术。患者中55%为男性,具有典型的血管并发症:高血压(87%)、高脂血症(68%)、冠心病(27%)、中风(19%)和糖尿病(16%);58%是活跃的烟草使用者,80%曾是烟草使用者。腋窝入路为外周血管内手术提供了便利,包括髂动脉介入(55例)、股动脉介入(44例)、肠系膜动脉介入(16例)、胫骨动脉介入(11例)以及栓塞或内脏动脉瘤治疗。所有手术都使用了6F鞘和超声引导下的Angio-Seal闭合装置,没有出现重大并发症、围手术期死亡或需要再次手术。11名患者(14%)出现了瘀伤和水肿等轻微并发症。其他轻微并发症如血肿、神经损伤、血栓形成、夹层、假性动脉瘤或肢体缺血等均未出现:结论:经皮腋动脉入路有望用于复杂的血管内介入治疗,安全性良好。其优点包括避免了不利的股动脉解剖结构,与桡动脉入路相比工作长度更长,并加强了对内脏治疗的控制。双侧髂动脉和下肢的治疗也可在一次治疗中完成。经皮腋动脉入路是增强血管内动脉介入能力的一种安全可靠的辅助手段。
{"title":"Feasibility and Safety of Endovascular Interventions via Percutaneous Access to the Axillary Artery","authors":"Caleb D. Alterman,&nbsp;Anton D. Perera,&nbsp;Prateek K. Gupta,&nbsp;Daniel M. Alterman","doi":"10.1016/j.avsg.2024.10.018","DOIUrl":"10.1016/j.avsg.2024.10.018","url":null,"abstract":"<div><h3>Background</h3><div>Endovascular treatment of peripheral arterial disease requires safe and reliable arterial access. This study evaluates the feasibility and safety of percutaneous axillary artery access for endovascular therapy. A variety of anatomic and logistic obstacles can be overcome with upper extremity access. In this retrospective case review, we describe our experience with percutaneous trans-axillary access for lower extremity peripheral arterial disease intervention.</div></div><div><h3>Methods</h3><div>Medical records of all patients undergoing axillary artery percutaneous access from December 2021 to August 2024 were reviewed. Demographic data, procedural details, and complications such as pseudoaneurysm, hematoma, nerve injury, and closure device success were analyzed. Technical success and perioperative complications—including bruising, edema, hematoma, nerve injury, infection, thrombosis, and pseudoaneurysm—were assessed. Clinical outcomes were analyzed via follow-up clinic records.</div></div><div><h3>Results</h3><div>During the study period, 79 axillary artery accesses were performed on 64 patients. The patients were 55% male and had typical vascular comorbidities: hypertension (87%), hyperlipidemia (68%), coronary artery disease (27%), stroke (19%), and diabetes (16%); 58% were active tobacco users, and 80% were former tobacco users. Axillary access facilitated peripheral endovascular procedures, including iliac intervention (55), femoral (44), mesenteric (16), tibial (11), and embolization or visceral aneurysm treatments. A 6F sheath and ultrasound-guided Angio-Seal closure device were uniformly employed, with no major complications, perioperative deaths, or reoperations required. Minor complications of bruising and edema were present in 11 patients (14%). Other minor complications such as hematoma, nerve injury, thrombosis, dissection, pseudoaneurysm, or limb ischemia were absent.</div></div><div><h3>Conclusions</h3><div>Percutaneous axillary artery access demonstrates promise for complex endovascular interventions with a favorable safety profile. Advantages include avoidance of unfavorable femoral anatomy, improved working length compared with radial access, and enhanced control of visceral therapy. Bilateral iliac and lower extremity therapy is feasible in a single treatment as well. Percutaneous axillary artery access is a safe, reliable adjunct for enhancing endovascular arterial intervention capabilities.</div></div>","PeriodicalId":8061,"journal":{"name":"Annals of vascular surgery","volume":"111 ","pages":"Pages 194-202"},"PeriodicalIF":1.4,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142709048","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Post-Thrombotic Syndrome Morbidity in Mechanical Thrombectomy Versus Pharmacomechanical Catheter-Directed Thrombolysis of Iliofemoral Deep Venous Thrombosis 髂股深静脉血栓的机械取栓术与药物机械导管定向溶栓术的血栓后综合征发病率。
IF 1.4 4区 医学 Q3 PERIPHERAL VASCULAR DISEASE Pub Date : 2025-02-01 DOI: 10.1016/j.avsg.2024.11.007
Jack K. Donohue , Kevin Li , Anthony Tang , Rachel J. Kann , Lena Vodovotz , Adham N. Abou Ali , Rabih A. Chaer , Natalie D. Sridharan

Background

Iliofemoral deep venous thrombosis is strongly associated with post-thrombotic syndrome (PTS). Interventional treatment options include catheter-directed thrombolysis and pharmacomechanical thrombectomy. More recently, there has been a wide dissemination of large-bore devices for mechanical thrombectomy (MT). Both treatment types have been shown to be effective in clinical practice; however, the rates of PTS after MT are poorly characterized.

Methods

We conducted a retrospective review of patients with acute iliofemoral deep venous thrombosis from 2007 to 2022. Patients were divided into 2 treatment groups: pharmacomechanical catheter-directed thrombolysis (PCDT) and MT with large-bore devices. Our primary endpoint was PTS (Villalta score >4). Secondary outcomes included vessel patency, mortality, and moderate/severe PTS (Villalta score >9). Predictors of PTS were analyzed using multivariable logistic regression.

Results

The median age of our cohort (n = 349) was 49 (interquartile range 35–63) years, 54.2% were female. There were 294 (84.2%) patients treated with PCDT. There were no significant baseline characteristic differences between patients treated with PCDT versus MT aside from increased preoperative anticoagulant use in the MT cohort. The overall rate of PTS was 19.1%. There were no differences in rates of PTS, moderate-severe PTS, stent patency, mortality between groups, or hospital length of stay. However, patients treated with MT had higher rates of single operating room visit during their admission treatment relative to patients that underwent PCDT (33.3% vs. 9.0%, P < 0.01) and decreased intensive care unit length of stay (2 (1–3) vs. 0.5 (0–2), P < 0.01). MT treatment was not a risk factor for the development of PTS (adjusted odds ratio [aOR] 0.73; [95% confidence interval {CI} 0.30, 1.74]; P = 0.47) or associated with increased Villalta score (β: −0.34; [95% CI–1.28, 0.60]; P = 0.47). Infrainguinal deep venous thrombosis extension (aOR 2.18; [95% CI 1.16, 4.09]; P = 0.02), prior deep venous thrombosis (aOR 2.67; [95% CI 1.38, 5.13]; P < 0.01), and a hypercoagulable state (aOR 2.32; [95% CI 1.19, 4.50]; P = 0.01) were associated with increased risk of PTS.

Conclusions

Treatment with large-bore MT was not a significant predictor for the development of PTS. MT appears safe, durable, and associated with greater rates of single operating room visit relative to PCDT, which suggests that rapid thrombus removal may be of value.
目的:髂股深静脉血栓(IFDVT)与血栓后综合征(PTS)密切相关。介入治疗方法包括导管引导溶栓(CDT)和药物机械血栓切除术(PMT)。最近,用于机械血栓切除术(MT)的大口径设备得到广泛推广。这两种治疗方法在临床实践中都被证明是有效的;然而,MT 治疗后的 PTS 发生率却鲜为人知:我们对 2007-2022 年间的急性 IFDVT 患者进行了回顾性研究。患者被分为两个治疗组:PCDT组和使用大口径设备的MT组。我们的主要终点是 PTS(Villalta 评分 > 4)。次要结局包括血管通畅、死亡率和中度/重度 PTS(Villalta 评分 > 9)。采用多变量逻辑回归分析了PTS的预测因素:队列(n = 349)的中位年龄为 49(IQR 35 - 63)岁,54.2% 为女性。294名患者(84.2%)接受了PCDT治疗。接受 PCDT 治疗的患者与接受 MT 治疗的患者之间没有明显的基线特征差异,只是 MT 组患者术前使用抗凝剂的情况有所增加。PTS总发生率为19.1%。两组患者的 PTS、中度-重度 PTS、支架通畅率、死亡率或住院时间(LOS)均无差异。然而,与接受 PCDT 的患者相比,接受 MT 治疗的患者在入院治疗期间的单次手术室就诊率更高(33.3% 对 9.0%,P < 0.01),重症监护室的住院时间更短(2 (1-3) 对 0.5 (0-2),P < 0.01)。MT 治疗不是 PTS 发生的风险因素(aOR 0.73;[95%CI 0.30,1.74];p = 0.47),也与 Villalta 评分增加无关(β:-0.34;[95%CI -1.28,0.60];p = 0.47)。腹股沟下 DVT 扩展(aOR 2.18;[95%CI 1.16,4.09];p = 0.02)、既往 DVT(aOR 2.67;[95%CI 1.38,5.13];p <0.01)和高凝状态(aOR 2.32;[95%CI 1.19,4.50];p = 0.01)与 PTS 风险增加相关:结论:使用大口径 MT 治疗并不能显著预测 PTS 的发生。与 PCDT 相比,MT 显得安全、持久,且单次手术室探视率更高,这表明快速清除血栓可能具有价值。
{"title":"Post-Thrombotic Syndrome Morbidity in Mechanical Thrombectomy Versus Pharmacomechanical Catheter-Directed Thrombolysis of Iliofemoral Deep Venous Thrombosis","authors":"Jack K. Donohue ,&nbsp;Kevin Li ,&nbsp;Anthony Tang ,&nbsp;Rachel J. Kann ,&nbsp;Lena Vodovotz ,&nbsp;Adham N. Abou Ali ,&nbsp;Rabih A. Chaer ,&nbsp;Natalie D. Sridharan","doi":"10.1016/j.avsg.2024.11.007","DOIUrl":"10.1016/j.avsg.2024.11.007","url":null,"abstract":"<div><h3>Background</h3><div>Iliofemoral deep venous thrombosis is strongly associated with post-thrombotic syndrome (PTS). Interventional treatment options include catheter-directed thrombolysis and pharmacomechanical thrombectomy. More recently, there has been a wide dissemination of large-bore devices for mechanical thrombectomy (MT). Both treatment types have been shown to be effective in clinical practice; however, the rates of PTS after MT are poorly characterized.</div></div><div><h3>Methods</h3><div>We conducted a retrospective review of patients with acute iliofemoral deep venous thrombosis from 2007 to 2022. Patients were divided into 2 treatment groups: pharmacomechanical catheter-directed thrombolysis (PCDT) and MT with large-bore devices. Our primary endpoint was PTS (Villalta score &gt;4). Secondary outcomes included vessel patency, mortality, and moderate/severe PTS (Villalta score &gt;9). Predictors of PTS were analyzed using multivariable logistic regression.</div></div><div><h3>Results</h3><div>The median age of our cohort (<em>n</em> = 349) was 49 (interquartile range 35–63) years, 54.2% were female. There were 294 (84.2%) patients treated with PCDT. There were no significant baseline characteristic differences between patients treated with PCDT versus MT aside from increased preoperative anticoagulant use in the MT cohort. The overall rate of PTS was 19.1%. There were no differences in rates of PTS, moderate-severe PTS, stent patency, mortality between groups, or hospital length of stay. However, patients treated with MT had higher rates of single operating room visit during their admission treatment relative to patients that underwent PCDT (33.3% vs. 9.0%, <em>P</em> &lt; 0.01) and decreased intensive care unit length of stay (2 (1–3) vs. 0.5 (0–2), <em>P</em> &lt; 0.01). MT treatment was not a risk factor for the development of PTS (adjusted odds ratio [aOR] 0.73; [95% confidence interval {CI} 0.30, 1.74]; <em>P</em> = 0.47) or associated with increased Villalta score (β: −0.34; [95% CI–1.28, 0.60]; <em>P</em> = 0.47). Infrainguinal deep venous thrombosis extension (aOR 2.18; [95% CI 1.16, 4.09]; <em>P</em> = 0.02), prior deep venous thrombosis (aOR 2.67; [95% CI 1.38, 5.13]; <em>P</em> &lt; 0.01), and a hypercoagulable state (aOR 2.32; [95% CI 1.19, 4.50]; <em>P</em> = 0.01) were associated with increased risk of PTS.</div></div><div><h3>Conclusions</h3><div>Treatment with large-bore MT was not a significant predictor for the development of PTS. MT appears safe, durable, and associated with greater rates of single operating room visit relative to PCDT, which suggests that rapid thrombus removal may be of value.</div></div>","PeriodicalId":8061,"journal":{"name":"Annals of vascular surgery","volume":"111 ","pages":"Pages 55-62"},"PeriodicalIF":1.4,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142709049","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Resistance Index as a Prognostic Factor for Patency in Distal Lower Limb Arterial Revascularization 阻力指数是下肢远端动脉血管再通的预后因素。
IF 1.4 4区 医学 Q3 PERIPHERAL VASCULAR DISEASE Pub Date : 2025-02-01 DOI: 10.1016/j.avsg.2024.10.019
Isadora Ísis Fernandes Vieira , Emmanuelle Tenório Albuquerque Godoi Berenguer de Barros E. Silva , Gabriela de Oliveira Buril , Carlos Henrique Nascimento Domingues da Silva , Esdras Marques Lins

Background

Critical limb ischemia (CLI) of the lower limbs (LLs) is a severe condition caused by peripheral arterial obstructive disease (PAOD). Surgical planning for CLI requires the study of limb circulation, and the vascular resistance index (RI) measured by Doppler ultrasound (US) has been used to aid in surgical decision-making. The objective is to correlate the RI of recipient arteries with the patency of LL revascularization surgeries in patients with CLI.

Methods

Prospective cohort study conducted from July 2021 to March 2023. The RI of the recipient arteries was evaluated preoperatively by US in 58 patients with CLI who underwent infrainguinal open or endovascular revascularizations, hospitalized in the Vascular Surgery Department of the Hospital das Clínicas of Empresa Brasileira de Serviços Hospitalares/Universidade Federal de Pernambuco. After 30 days of surgery, all patients were evaluated for the presence of pulses in the revascularized limb and the ankle brachial index (ABI) was measured in all cases. Statistical analysis was conducted with a 95% confidence level, and the Student's t-test was used to compare 2 independent samples.

Results

Clinical evaluation and ABI assessment of revascularization patency after 30 days revealed that infragenicular revascularizations that occluded had an average RI of 0.72 (SD ± 0.16), while patent revascularizations had a mean RI of 0.69 (SD ± 0.17) without statistical significance (P = 0.658).

Conclusions

Despite the lack of statistical significance, the study observed that a lower preoperative RI of the distal recipient artery was associated with greater patency of the revascularization surgery after 30 days.
背景:下肢严重缺血(CLI)是由外周动脉阻塞性疾病(PAOD)引起的一种严重疾病。CLI的手术计划需要对肢体循环进行研究,多普勒超声(US)测量的血管阻力指数(RI)已被用于辅助手术决策:将受体动脉RI与CLI患者LL血管再通手术的通畅性相关联:方法:2021年7月至2023年3月进行的前瞻性队列研究。58名慢性肢体缺血(CLI)患者在EBSERH/UFPE医院(HC-EBSERH/UFPE)血管外科住院,接受了腹股沟下开放或血管内血运重建手术,术前通过US对受体动脉的RI进行了评估。手术30天后,对所有患者的血管再通肢体是否有搏动进行评估,并对所有病例的踝肱指数(ABI)进行测量:结果:临床评估和 30 天后血管再通的 ABI 评估显示,闭塞的膝下血管再通平均 RI 为 0.72(sd ± 0.16),而通畅的血管再通平均 RI 为 0.69(sd ± 0.17),但无统计学意义(p = 0.658):尽管缺乏统计学意义,但该研究观察到远端受体动脉术前 RI 较低与 30 天后血管再通手术的通畅率较高有关。
{"title":"Resistance Index as a Prognostic Factor for Patency in Distal Lower Limb Arterial Revascularization","authors":"Isadora Ísis Fernandes Vieira ,&nbsp;Emmanuelle Tenório Albuquerque Godoi Berenguer de Barros E. Silva ,&nbsp;Gabriela de Oliveira Buril ,&nbsp;Carlos Henrique Nascimento Domingues da Silva ,&nbsp;Esdras Marques Lins","doi":"10.1016/j.avsg.2024.10.019","DOIUrl":"10.1016/j.avsg.2024.10.019","url":null,"abstract":"<div><h3>Background</h3><div>Critical limb ischemia (CLI) of the lower limbs (LLs) is a severe condition caused by peripheral arterial obstructive disease (PAOD). Surgical planning for CLI requires the study of limb circulation, and the vascular resistance index (RI) measured by Doppler ultrasound (US) has been used to aid in surgical decision-making. The objective is to correlate the RI of recipient arteries with the patency of LL revascularization surgeries in patients with CLI.</div></div><div><h3>Methods</h3><div>Prospective cohort study conducted from July 2021 to March 2023. The RI of the recipient arteries was evaluated preoperatively by US in 58 patients with CLI who underwent infrainguinal open or endovascular revascularizations, hospitalized in the Vascular Surgery Department of the Hospital das Clínicas of Empresa Brasileira de Serviços Hospitalares/Universidade Federal de Pernambuco. After 30 days of surgery, all patients were evaluated for the presence of pulses in the revascularized limb and the ankle brachial index (ABI) was measured in all cases. Statistical analysis was conducted with a 95% confidence level, and the Student's <em>t</em>-test was used to compare 2 independent samples.</div></div><div><h3>Results</h3><div>Clinical evaluation and ABI assessment of revascularization patency after 30 days revealed that infragenicular revascularizations that occluded had an average RI of 0.72 (SD ± 0.16), while patent revascularizations had a mean RI of 0.69 (SD ± 0.17) without statistical significance (<em>P</em> = 0.658).</div></div><div><h3>Conclusions</h3><div>Despite the lack of statistical significance, the study observed that a lower preoperative RI of the distal recipient artery was associated with greater patency of the revascularization surgery after 30 days.</div></div>","PeriodicalId":8061,"journal":{"name":"Annals of vascular surgery","volume":"111 ","pages":"Pages 360-366"},"PeriodicalIF":1.4,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142715056","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Artificial Intelligence in Diagnosing and Managing Vascular Surgery Patients: An Experimental Study Using the GPT-4 Model 人工智能在血管外科患者诊断和管理中的应用:使用 GPT-4 模型的实验研究。
IF 1.4 4区 医学 Q3 PERIPHERAL VASCULAR DISEASE Pub Date : 2025-02-01 DOI: 10.1016/j.avsg.2024.11.014
Vangelis G. Alexiou , Bauer E. Sumpio , Areti Vassiliou , Stavros K. Kakkos , George Geroulakos

Background

The introduction of artificial intelligence (AI) has led to groundbreaking advancements across many scientific fields. Machine learning algorithms have enabled AI models to learn, adapt, and solve complex problems in previously unimaginable ways. Natural language processing allows these models to comprehend and respond to inquiries in a natural and humanly understandable way. We sought to investigate the application and performance of an AI chatbot in the diagnosis and management of vascular surgery patients.

Methods

An experimental study to evaluate the performance of GPT-4 AI model across 57 clinical scenarios derived from a textbook in vascular surgery. Specific prompts were devised to address the AI model and task it to identify symptoms, diagnose conditions, and select appropriate therapeutic approaches. Answers were scored, descriptive statistics were produced, and means were compared across topics. The reasoning and evidence used in the cases in which AI performed poorly were critically reviewed.

Results

The AI model correctly answered over 65% of the 385 questions. Performance variation between and within 13 vascular surgery topics did not show any statistically significant differences. Analysis of the questions where the model failed by more than 50% suggests a gap in the ability to interpret and process multifaceted medical information. Twenty-seven percent of these errors were attributed to potential lack of understanding of complex clinical scenarios. The AI model also quoted incorrect or outdated information in 14% of cases and showed an inability to comprehend context, nuances, and medical classification systems in 11% of the cases.

Conclusions

GPT-4 demonstrated potential to provide clinically relevant answers for most of the tested scenarios. However, its reasoning must still be carefully analyzed for exactitude and clinical validity. While language models show promise as valuable tools for clinicians, it is essential to recognize their role as supportive mechanisms rather than standalone solutions.
目的:人工智能(AI)的引入为许多科学领域带来了突破性的进步。机器学习算法使人工智能模型能够以以前无法想象的方式学习、适应和解决复杂问题。自然语言处理(NLP)使这些模型能够以自然和人类可理解的方式理解和回应询问。我们试图研究人工智能聊天机器人在血管外科患者诊断和管理中的应用和性能:设计:一项实验研究,评估 GPT-4 人工智能模型在 57 个临床场景中的表现,这些场景来自一本血管外科教科书:方法:针对人工智能模型设计了具体的提示,要求其识别症状、诊断病情并选择适当的治疗方法。对答案进行评分,得出描述性统计结果,并对不同题目的平均值进行比较。对人工智能表现不佳的案例所使用的推理和证据进行了严格审查:结果:人工智能模型正确回答了 385 个问题中的 65% 以上。13 个血管外科题目之间和题目内部的成绩差异在统计学上没有任何显著性差异。对模型失败率超过 50%的问题进行分析后发现,在解释和处理多方面医学信息的能力方面存在差距。其中 27% 的错误归因于可能缺乏对复杂临床场景的理解。人工智能模型还在14%的案例中引用了错误或过时的信息,并在11%的案例中显示出无法理解上下文、细微差别和医疗分类系统:结论:GPT-4 展示了为大多数测试场景提供临床相关答案的潜力。结论:GPT-4 显示出了为大多数测试场景提供临床相关答案的潜力,但仍需对其推理的准确性和临床有效性进行仔细分析。虽然语言模型有望成为临床医生的宝贵工具,但必须认识到其作为辅助机制而非独立解决方案的作用。
{"title":"Artificial Intelligence in Diagnosing and Managing Vascular Surgery Patients: An Experimental Study Using the GPT-4 Model","authors":"Vangelis G. Alexiou ,&nbsp;Bauer E. Sumpio ,&nbsp;Areti Vassiliou ,&nbsp;Stavros K. Kakkos ,&nbsp;George Geroulakos","doi":"10.1016/j.avsg.2024.11.014","DOIUrl":"10.1016/j.avsg.2024.11.014","url":null,"abstract":"<div><h3>Background</h3><div>The introduction of artificial intelligence (AI) has led to groundbreaking advancements across many scientific fields. Machine learning algorithms have enabled AI models to learn, adapt, and solve complex problems in previously unimaginable ways. Natural language processing allows these models to comprehend and respond to inquiries in a natural and humanly understandable way. We sought to investigate the application and performance of an AI chatbot in the diagnosis and management of vascular surgery patients.</div></div><div><h3>Methods</h3><div>An experimental study to evaluate the performance of GPT-4 AI model across 57 clinical scenarios derived from a textbook in vascular surgery. Specific prompts were devised to address the AI model and task it to identify symptoms, diagnose conditions, and select appropriate therapeutic approaches. Answers were scored, descriptive statistics were produced, and means were compared across topics. The reasoning and evidence used in the cases in which AI performed poorly were critically reviewed.</div></div><div><h3>Results</h3><div>The AI model correctly answered over 65% of the 385 questions. Performance variation between and within 13 vascular surgery topics did not show any statistically significant differences. Analysis of the questions where the model failed by more than 50% suggests a gap in the ability to interpret and process multifaceted medical information. Twenty-seven percent of these errors were attributed to potential lack of understanding of complex clinical scenarios. The AI model also quoted incorrect or outdated information in 14% of cases and showed an inability to comprehend context, nuances, and medical classification systems in 11% of the cases.</div></div><div><h3>Conclusions</h3><div>GPT-4 demonstrated potential to provide clinically relevant answers for most of the tested scenarios. However, its reasoning must still be carefully analyzed for exactitude and clinical validity. While language models show promise as valuable tools for clinicians, it is essential to recognize their role as supportive mechanisms rather than standalone solutions.</div></div>","PeriodicalId":8061,"journal":{"name":"Annals of vascular surgery","volume":"111 ","pages":"Pages 260-267"},"PeriodicalIF":1.4,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142715132","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Open Revascularization for Acute Mesenteric Ischemia is Associated with Increased Morbidity and Mortality when Compared to Endovascular Intervention 与血管内介入治疗相比,急性肠系膜缺血的开放性血管重建术会增加发病率和死亡率。
IF 1.4 4区 医学 Q3 PERIPHERAL VASCULAR DISEASE Pub Date : 2025-02-01 DOI: 10.1016/j.avsg.2024.10.013
Andrew S. Warren , Blake Murphy , Nallely Saldana-Ruiz , Kirsten Dansey , Sara L. Zettervall

Objectives

Historically, open approaches have been considered the primary treatment for acute mesenteric ischemia (AMI) due to the potential for bowel resection. However, the use of endovascular therapy is increasing. Given the paucity of current data, this study aims to compare outcomes between open and endovascular interventions for AMI.

Methods

Patients treated for AMI between 2011 and 2022 were identified in the National Surgical Quality Improvement Program (NSQIP) by ICD-9 and ICD-10 codes. Intervention type (open vs. endovascular) was obtained from CPT codes. Demographics, comorbidities, pre-operative laboratory values, and 30-day outcomes were compared between intervention types. Multivariable analysis was utilized to adjust for differences between groups with a patient's need for bowel resection included to account for disease severity.

Results

A total of 1,172 patients underwent revascularization for AMI (1,023 open, 149 endovascular). Among those treated with open revascularization, 577 (56%) underwent thrombectomies/embolectomy, 125 (12%) underwent thromboendarterectomy, and 321 (31%) received bypasses. Of the patients who underwent endovascular revascularizations, 101 (68%) received a stent, 23 (15%) underwent angioplasty without stenting, and 25 (17%) underwent lysis/thrombectomy. Patients who underwent endovascular revascularization had higher rates of smoking (36% open vs. 47% endovascular; P < 0.01), were more likely to have an eGFR less than 30 (6% open vs. 15% endovascular; P < 0.01), and underwent more bowel resections at the time of the initial operation (33% open vs. 48% endovascular; P < 0.01). For outcomes, patients who underwent open repair had longer median hospital stays (10 days vs. 7 days; P < 0.01). All other outcomes including 30-day mortality were similar on univariate analysis. Following adjustment for the need for bowel resection and comorbidities, 30-day-mortality (OR 1.96, 95% CI: 1.28–3.02), failure to wean from ventilator (OR 1.56 95% CI: 1.05–2.34), and length of hospital stay (β 3.7 days, 95% CI: 1.8–5.6) were higher among patients treated with open surgery.

Conclusions

After accounting for the need for bowel resection and comorbidities, open revascularization for AMI is associated with higher peri-operative morbidity and mortality compared to endovascular intervention. Thus, the need for bowel resection should not preclude endovascular treatment for AMI.
目的:从历史上看,由于可能切除肠道,开放式方法一直被认为是治疗急性肠系膜缺血(AMI)的主要方法。然而,血管内治疗的使用正在增加。鉴于目前的数据很少,本研究旨在比较急性肠系膜缺血开放式和血管内介入治疗的结果:方法:根据 ICD-9 和 ICD-10 编码,在国家外科质量改进计划(NSQIP)中对 2011 年至 2022 年间接受 AMI 治疗的患者进行识别。介入类型(开放式与血管内介入)来自 CPT 代码。对不同介入类型的人口统计学、合并症、术前实验室值和 30 天预后进行了比较。采用多变量分析来调整组间差异,并将患者是否需要切除肠道纳入考虑疾病严重程度的因素:共有1172名患者因急性心肌梗死接受了血管再通手术(1023人接受了开放性手术,149人接受了血管内手术)。在接受开放性血管重建术的患者中,577 人(56%)接受了血栓切除术/肠切除术,125 人(12%)接受了血栓内膜切除术,321 人(31%)接受了搭桥术。在接受血管内再通术的患者中,101 人(68%)接受了支架植入术,23 人(15%)接受了血管成形术而未植入支架,25 人(17%)接受了溶栓/血栓切除术。接受血管内血运重建的患者吸烟率较高(36%为开放手术,47%为血管内手术;P结论:考虑到切除肠道的需要和合并症,与血管内介入治疗相比,开放性急性心肌梗死血管重建术的围手术期发病率和死亡率更高。因此,不应该因为需要切除肠道而排除血管内治疗急性心肌梗死。
{"title":"Open Revascularization for Acute Mesenteric Ischemia is Associated with Increased Morbidity and Mortality when Compared to Endovascular Intervention","authors":"Andrew S. Warren ,&nbsp;Blake Murphy ,&nbsp;Nallely Saldana-Ruiz ,&nbsp;Kirsten Dansey ,&nbsp;Sara L. Zettervall","doi":"10.1016/j.avsg.2024.10.013","DOIUrl":"10.1016/j.avsg.2024.10.013","url":null,"abstract":"<div><h3>Objectives</h3><div>Historically, open approaches have been considered the primary treatment for acute mesenteric ischemia (AMI) due to the potential for bowel resection. However, the use of endovascular therapy is increasing. Given the paucity of current data, this study aims to compare outcomes between open and endovascular interventions for AMI.</div></div><div><h3>Methods</h3><div>Patients treated for AMI between 2011 and 2022 were identified in the National Surgical Quality Improvement Program (NSQIP) by ICD-9 and ICD-10 codes. Intervention type (open vs. endovascular) was obtained from CPT codes. Demographics, comorbidities, pre-operative laboratory values, and 30-day outcomes were compared between intervention types. Multivariable analysis was utilized to adjust for differences between groups with a patient's need for bowel resection included to account for disease severity.</div></div><div><h3>Results</h3><div>A total of 1,172 patients underwent revascularization for AMI (1,023 open, 149 endovascular). Among those treated with open revascularization, 577 (56%) underwent thrombectomies/embolectomy, 125 (12%) underwent thromboendarterectomy, and 321 (31%) received bypasses. Of the patients who underwent endovascular revascularizations, 101 (68%) received a stent, 23 (15%) underwent angioplasty without stenting, and 25 (17%) underwent lysis/thrombectomy. Patients who underwent endovascular revascularization had higher rates of smoking (36% open vs. 47% endovascular; <em>P</em> &lt; 0.01), were more likely to have an eGFR less than 30 (6% open vs. 15% endovascular; <em>P</em> &lt; 0.01), and underwent more bowel resections at the time of the initial operation (33% open vs. 48% endovascular; <em>P</em> &lt; 0.01). For outcomes, patients who underwent open repair had longer median hospital stays (10 days vs. 7 days; <em>P</em> &lt; 0.01). All other outcomes including 30-day mortality were similar on univariate analysis. Following adjustment for the need for bowel resection and comorbidities, 30-day-mortality (OR 1.96, 95% CI: 1.28–3.02), failure to wean from ventilator (OR 1.56 95% CI: 1.05–2.34), and length of hospital stay (β 3.7 days, 95% CI: 1.8–5.6) were higher among patients treated with open surgery.</div></div><div><h3>Conclusions</h3><div>After accounting for the need for bowel resection and comorbidities, open revascularization for AMI is associated with higher peri-operative morbidity and mortality compared to endovascular intervention. Thus, the need for bowel resection should not preclude endovascular treatment for AMI.</div></div>","PeriodicalId":8061,"journal":{"name":"Annals of vascular surgery","volume":"111 ","pages":"Pages 386-392"},"PeriodicalIF":1.4,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142695190","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Diagnostic Comparison Study between Maximal Systolic Acceleration and Acceleration Time to Detect Peripheral Arterial Disease 最大收缩加速度和加速时间在检测外周动脉疾病方面的诊断比较研究。
IF 1.4 4区 医学 Q3 PERIPHERAL VASCULAR DISEASE Pub Date : 2025-02-01 DOI: 10.1016/j.avsg.2024.10.021
Siem A. Willems, Obrecht O. van Bennekom, Abbey Schepers, Jan van Schaik, Joost R. van der Vorst, Jaap F. Hamming, Jeroen J.W.M. Brouwers

Background

Detecting peripheral arterial disease (PAD) can be particularly challenging in patients with diabetes mellitus (DM) or chronic kidney disease (CKD) due to medial arterial calcification (MAC). Current bedside tests, such as the ankle-brachial index, are less accurate in these patient groups. The primary aim of this study is to evaluate the diagnostic accuracy of point-of-care duplex ultrasound parameters maximal systolic acceleration (ACCmax) and acceleration time (AT) to detect PAD, including a comparison of both metrics.

Methods

Patients suspected of having PAD, who underwent point-of-care duplex ultrasound measurements (ACCmax and AT) of the posterior tibial artery (PTA) and/or anterior tibial artery (ATA) at ankle level along with computed tomography angiography were eligible for inclusion. PAD was defined as a stenosis >50% on computed tomography angiography. Diagnostic accuracy of AT was evaluated at calculated (Youden index) and prespecified cut-off values (121 ms), using the sensitivity, specificity, positive likelihood ratio, negative likelihood ratios, and area under the curve. The McNemar test compared ACCmax with AT at prespecified and calculated cut-off values. Subgroup analyses of patients prone to MAC (i.e., those with DM and/or CKD) were also performed.

Results

This study included 184 patients (267 legs) with a high prevalence of DM (53%) and CKD (36%). The diagnostic accuracy of AT to identify PAD for PTA showed a sensitivity of 84%, specificity of 98%, positive likelihood ratio of 42.00, negative likelihood ratio of 0.16 and area under the curve of 0.96. Regarding the ATA, the results were 81%, 93%, 11.57, 0.20, and 0.92, respectively. Statistical comparisons favored ACCmax over AT in detecting PAD at prespecified and calculated cut-off values for both the PTA and ATA (P < 0.001). Additionally, in patients prone to MAC, ACCmax also outperformed AT in detecting PAD (P values ranging from <0.001 to 0.039). For patients without PAD, no significant differences were observed in the ability to rule out the disease.

Conclusions

ACCmax proved to be more accurate than AT in detecting PAD, also in patients prone to MAC. While no significant difference was found between ACCmax and AT in their diagnostic accuracy to exclude PAD, ACCmax should be favored in the diagnostic work-up in patients suspected of PAD due to its superior ability to detect an arterial stenosis.
目的:糖尿病(DM)或慢性肾病(CKD)患者由于内侧动脉钙化(MAC),检测外周动脉疾病(PAD)尤其具有挑战性。目前的床旁测试,如踝肱指数,对这些患者群体的准确性较低。本研究的主要目的是评估床旁双工超声(DUS)参数最大收缩加速度(ACCmax)和加速时间(AT)在检测 PAD 方面的诊断准确性,包括两种指标的比较:疑似 PAD 患者在接受计算机断层扫描血管造影术 (CTA) 的同时,还接受了踝关节水平的胫后动脉 (PTA) 和/或胫前动脉 (ATA) 的护理点 DUS 测量(ACCmax 和 AT)。PAD的定义是CTA血管狭窄>50%。使用灵敏度、特异性、阳性似然比 (PLR)、阴性似然比 (NLR) 和曲线下面积 (AUC) 对计算得出的(尤登指数)和预先指定的截断值(121 毫秒)评估 AT 的诊断准确性。McNemar 检验比较了 ACCmax 与 AT 在预先指定和计算的临界值上的差异。还对易患 MAC 的患者(即患有糖尿病和/或慢性肾脏病的患者)进行了分组分析:该研究纳入了 184 名患者(267 条腿),其中糖尿病(53%)和慢性肾脏病(36%)的发病率较高。AT 对 PTA 鉴定 PAD 的诊断准确性显示灵敏度为 84%,特异性为 98%,PLR 为 42.00,NLR 为 0.16,AUC 为 0.96。而 ATA 的结果分别为 81%、93%、11.57、0.20 和 0.92。统计比较结果表明,ACCmax 在按预先指定和计算的 PTA 和 ATA 临界值检测 PAD 方面优于 AT(pmax 在检测 PAD 方面也优于 AT(p 值范围为 结论:ACCmax 在检测 PAD 方面也优于 AT(p 值范围为 结论:ACCmax 在检测 PAD 方面也优于 AT):事实证明,ACCmax 在检测 PAD 方面比 AT 更准确,同样适用于易患 MAC 的患者。虽然 ACCmax 和 AT 在排除 PAD 的诊断准确性上没有明显差异,但由于 ACCmax 检测动脉狭窄的能力更强,因此在诊断疑似 PAD 患者时应首选 ACCmax。
{"title":"A Diagnostic Comparison Study between Maximal Systolic Acceleration and Acceleration Time to Detect Peripheral Arterial Disease","authors":"Siem A. Willems,&nbsp;Obrecht O. van Bennekom,&nbsp;Abbey Schepers,&nbsp;Jan van Schaik,&nbsp;Joost R. van der Vorst,&nbsp;Jaap F. Hamming,&nbsp;Jeroen J.W.M. Brouwers","doi":"10.1016/j.avsg.2024.10.021","DOIUrl":"10.1016/j.avsg.2024.10.021","url":null,"abstract":"<div><h3>Background</h3><div>Detecting peripheral arterial disease (PAD) can be particularly challenging in patients with diabetes mellitus (DM) or chronic kidney disease (CKD) due to medial arterial calcification (MAC). Current bedside tests, such as the ankle-brachial index, are less accurate in these patient groups. The primary aim of this study is to evaluate the diagnostic accuracy of point-of-care duplex ultrasound parameters maximal systolic acceleration (ACC<sub>max</sub>) and acceleration time (AT) to detect PAD, including a comparison of both metrics.</div></div><div><h3>Methods</h3><div>Patients suspected of having PAD, who underwent point-of-care duplex ultrasound measurements (ACC<sub>max</sub> and AT) of the posterior tibial artery (PTA) and/or anterior tibial artery (ATA) at ankle level along with computed tomography angiography were eligible for inclusion. PAD was defined as a stenosis &gt;50% on computed tomography angiography. Diagnostic accuracy of AT was evaluated at calculated (Youden index) and prespecified cut-off values (121 ms), using the sensitivity, specificity, positive likelihood ratio, negative likelihood ratios, and area under the curve. The McNemar test compared ACC<sub>max</sub> with AT at prespecified and calculated cut-off values. Subgroup analyses of patients prone to MAC (i.e., those with DM and/or CKD) were also performed.</div></div><div><h3>Results</h3><div>This study included 184 patients (267 legs) with a high prevalence of DM (53%) and CKD (36%). The diagnostic accuracy of AT to identify PAD for PTA showed a sensitivity of 84%, specificity of 98%, positive likelihood ratio of 42.00, negative likelihood ratio of 0.16 and area under the curve of 0.96. Regarding the ATA, the results were 81%, 93%, 11.57, 0.20, and 0.92, respectively. Statistical comparisons favored ACC<sub>max</sub> over AT in detecting PAD at prespecified and calculated cut-off values for both the PTA and ATA (<em>P</em> &lt; 0.001). Additionally, in patients prone to MAC, ACC<sub>max</sub> also outperformed AT in detecting PAD (<em>P</em> values ranging from &lt;0.001 to 0.039). For patients without PAD, no significant differences were observed in the ability to rule out the disease.</div></div><div><h3>Conclusions</h3><div>ACC<sub>max</sub> proved to be more accurate than AT in detecting PAD, also in patients prone to MAC. While no significant difference was found between ACC<sub>max</sub> and AT in their diagnostic accuracy to exclude PAD, ACC<sub>max</sub> should be favored in the diagnostic work-up in patients suspected of PAD due to its superior ability to detect an arterial stenosis.</div></div>","PeriodicalId":8061,"journal":{"name":"Annals of vascular surgery","volume":"111 ","pages":"Pages 203-211"},"PeriodicalIF":1.4,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142715116","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Off the Cover
IF 1.4 4区 医学 Q3 PERIPHERAL VASCULAR DISEASE Pub Date : 2025-02-01 DOI: 10.1016/j.avsg.2025.01.008
T.M. Sullivan
{"title":"Off the Cover","authors":"T.M. Sullivan","doi":"10.1016/j.avsg.2025.01.008","DOIUrl":"10.1016/j.avsg.2025.01.008","url":null,"abstract":"","PeriodicalId":8061,"journal":{"name":"Annals of vascular surgery","volume":"111 ","pages":"Pages 409-410"},"PeriodicalIF":1.4,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143063330","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cognitive Impairment is Common and Unrecognized in Vascular Surgery Patients 认知障碍在血管外科手术患者中很常见,但却未被认识到。
IF 1.4 4区 医学 Q3 PERIPHERAL VASCULAR DISEASE Pub Date : 2025-02-01 DOI: 10.1016/j.avsg.2024.11.003
Emily J. Draper , Tam B. Nguyen , Amin A. Mirzaie , Dan Neal , Salvatore T. Scali , Thomas S. Huber , Scott A. Berceli , Gilbert R. Upchurch Jr. , Samir K. Shah

Background

Patients’ capacities to understand and act upon healthcare information is crucial to decision-making and high-quality care. Cognitive impairment (CI) has been associated with adverse outcomes across a range of diseases and surgeries. Despite the importance of CI, there is little to no information on its prevalence and severity in vascular surgery patients in the United States. We therefore conducted a prospective observational study to better characterize the prevalence and severity of CI in a contemporary vascular surgery practice.

Methods

We enrolled 111 outpatients attending a vascular surgery clinic using pragmatic consecutive sampling. Patients were excluded if they had a previous diagnosis of blindness, deafness, or dementia. Subjects completed a demographic survey and the Montreal Cognitive Assessment (MoCA), which was administered by a trained proctor. Chart review was used to assess comorbidities. The MoCA is a validated tool consisting of tasks such as clock drawing for assessing CI. It has a lower educational bias and higher sensitivity for detecting mild impairment compared to other examinations. The MoCA is scored from 0–30 based on an objective grading system. Scores between 0–9, 10–17, 18–25, and 26–30 indicate severe, moderate, mild, and no CI, respectively. Statistical analysis, including multivariable modeling, was performed using SAS (SAS Institute, Cary, NC).

Results

Of 163 patients, our analysis included 111 consecutive vascular patients who completed the MoCA. The average age of the entire cohort was 64.1 years, and 58.6% were male. The majority of the patients in the study were White (80.1%). The mean MoCA score of the entire cohort was 22.6 (mild CI). Of all subjects, 77% had CI: 68% with mild and 9% with moderate CI. Hypertension (P = 0.024), congestive heart failure (CHF) (P = 0.028), fewer years of education (P = 0.032), and Medicaid enrollment (P = 0.046) all had significant univariate associations with CI. There was no statistically significant difference between age (P = 0.11) or the primary vascular diagnosis disease for which the patient sought treatment and CI (P = 0.49). Multivariable models demonstrated that only CHF (odds ratio 3.8, P = 0.046) was statistically significantly associated with risk of CI.

Conclusions

In this first-time prospective study of the entire spectrum of vascular patients in the United States, we found that nearly 4 of every 5 vascular surgery patients have undiagnosed CI. Furthermore, we found that having CHF was associated with a higher likelihood of CI. Given the implications on consent, decision-making, and postoperative care, future work should focus on enrollment of a larger cohort along with an examination of the impact of CI on mortality, length of stay, and other outcomes.
目的:患者理解医疗信息并据此采取行动的能力对决策和高质量的医疗服务至关重要。认知障碍(CI)与一系列疾病和手术的不良后果有关。尽管 CI 很重要,但在美国,关于其在血管外科患者中的流行率和严重程度的信息却几乎没有。因此,我们开展了一项前瞻性观察研究,以更好地描述当代血管外科实践中 CI 的流行率和严重程度:方法:我们采用实用连续抽样法招募了 111 名血管外科门诊患者。曾被诊断为失明、失聪或痴呆的患者将被排除在外。受试者完成了一项人口统计学调查和蒙特利尔认知评估(MoCA),该评估由一名经过培训的监考人员进行。病历审查用于评估合并症。MoCA 是一种经过验证的工具,包括绘制时钟等任务,用于评估 CI。与其他检查相比,它的教育偏差较小,检测轻度损伤的灵敏度较高。MoCA 的评分范围为 0-30 分,采用客观的评分系统。0-9、10-17、18-25 和 26-30 分分别表示重度、中度、轻度和无 CI。统计分析(包括多变量模型)使用 SAS 进行:在 163 名患者中,我们的分析包括 111 名连续完成 MoCA 的血管性患者。整个群体的平均年龄为 64.1 岁,58.6% 为男性。研究中的大多数患者为白人(80.1%)。整个群体的平均 MoCA 得分为 22.6(轻度 CI)。所有受试者中有 77% 患有 CI:68% 患有轻度 CI,9% 患有中度 CI。高血压(p=.024)、充血性心力衰竭(CHF)(p=.028)、受教育年限较少(p=.032)和医疗补助(Medicaid)登记(p=.046)均与 CI 存在显著的单变量关联。年龄(p=.11)或患者寻求治疗的主要血管诊断疾病与 CI(p=.49)之间没有明显的统计学差异。多变量模型显示,只有 CHF(OR 3.8,p=.046)与 CI 风险有明显的统计学相关性:在这项首次对美国所有血管病患进行的前瞻性研究中,我们发现每 5 位血管手术患者中就有近 4 位存在未确诊的认知障碍。此外,我们还发现患有慢性心力衰竭的患者发生认知障碍的可能性更高。考虑到这对同意、决策和术后护理的影响,未来的工作重点应该是招募更大规模的人群,同时研究 CI 对死亡率、住院时间和其他结果的影响。
{"title":"Cognitive Impairment is Common and Unrecognized in Vascular Surgery Patients","authors":"Emily J. Draper ,&nbsp;Tam B. Nguyen ,&nbsp;Amin A. Mirzaie ,&nbsp;Dan Neal ,&nbsp;Salvatore T. Scali ,&nbsp;Thomas S. Huber ,&nbsp;Scott A. Berceli ,&nbsp;Gilbert R. Upchurch Jr. ,&nbsp;Samir K. Shah","doi":"10.1016/j.avsg.2024.11.003","DOIUrl":"10.1016/j.avsg.2024.11.003","url":null,"abstract":"<div><h3>Background</h3><div>Patients’ capacities to understand and act upon healthcare information is crucial to decision-making and high-quality care. Cognitive impairment (CI) has been associated with adverse outcomes across a range of diseases and surgeries. Despite the importance of CI, there is little to no information on its prevalence and severity in vascular surgery patients in the United States. We therefore conducted a prospective observational study to better characterize the prevalence and severity of CI in a contemporary vascular surgery practice.</div></div><div><h3>Methods</h3><div>We enrolled 111 outpatients attending a vascular surgery clinic using pragmatic consecutive sampling. Patients were excluded if they had a previous diagnosis of blindness, deafness, or dementia. Subjects completed a demographic survey and the Montreal Cognitive Assessment (MoCA), which was administered by a trained proctor. Chart review was used to assess comorbidities. The MoCA is a validated tool consisting of tasks such as clock drawing for assessing CI. It has a lower educational bias and higher sensitivity for detecting mild impairment compared to other examinations. The MoCA is scored from 0–30 based on an objective grading system. Scores between 0–9, 10–17, 18–25, and 26–30 indicate severe, moderate, mild, and no CI, respectively. Statistical analysis, including multivariable modeling, was performed using SAS (SAS Institute, Cary, NC).</div></div><div><h3>Results</h3><div>Of 163 patients, our analysis included 111 consecutive vascular patients who completed the MoCA. The average age of the entire cohort was 64.1 years, and 58.6% were male. The majority of the patients in the study were White (80.1%). The mean MoCA score of the entire cohort was 22.6 (mild CI). Of all subjects, 77% had CI: 68% with mild and 9% with moderate CI. Hypertension (<em>P</em> = 0.024), congestive heart failure (CHF) (<em>P</em> = 0.028), fewer years of education (<em>P</em> = 0.032), and Medicaid enrollment (<em>P</em> = 0.046) all had significant univariate associations with CI. There was no statistically significant difference between age (<em>P</em> = 0.11) or the primary vascular diagnosis disease for which the patient sought treatment and CI (<em>P</em> = 0.49). Multivariable models demonstrated that only CHF (odds ratio 3.8, <em>P</em> = 0.046) was statistically significantly associated with risk of CI.</div></div><div><h3>Conclusions</h3><div>In this first-time prospective study of the entire spectrum of vascular patients in the United States, we found that nearly 4 of every 5 vascular surgery patients have undiagnosed CI. Furthermore, we found that having CHF was associated with a higher likelihood of CI. Given the implications on consent, decision-making, and postoperative care, future work should focus on enrollment of a larger cohort along with an examination of the impact of CI on mortality, length of stay, and other outcomes.</div></div>","PeriodicalId":8061,"journal":{"name":"Annals of vascular surgery","volume":"111 ","pages":"Pages 187-193"},"PeriodicalIF":1.4,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142695146","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Predictive Factors Driving Positive Awake Test in Carotid Endarterectomy Using Machine Learning 利用机器学习预测颈动脉内膜剥脱术清醒试验阳性的因素
IF 1.4 4区 医学 Q3 PERIPHERAL VASCULAR DISEASE Pub Date : 2025-02-01 DOI: 10.1016/j.avsg.2024.10.011
Juliana Pereira-Macedo , Ana Daniela Pias , Luís Duarte-Gamas , Piotr Myrcha , José P. Andrade , Nuno António , Ana Marreiros , João Rocha-Neves

Background

Positive neurologic awake testing during the carotid cross-clamping may be present in around 8% of patients undergoing carotid endarterectomy (CEA). The present work aimed to assess the accuracy of an artificial intelligence (AI)-powered risk calculator in predicting intraoperative neurologic deficits (INDs).

Methods

Data was collected from carotid interventions performed between January 2012 and January 2023 under regional anesthesia. Patients with IND were selected along with consecutive controls without IND in a case-control study design. A predictive model for IND was developed using machine learning, specifically Extreme Gradient Boosting (XGBoost) model, and its performance was assessed and compared to an existing predictive model. Shapley Additive exPlanations (SHAP) analysis was employed for the model interpretation.

Results

Among 216 patients, 108 experienced IND during CEA. The AI-based predictive model achieved a robust area under the curve of 0.82, with an accuracy of 0.75, precision of 0.88, sensitivity of 0.59, and F1Score of 0.71. High body mass index (BMI) increased contralateral carotid stenosis, and a history of limb paresis or plegia were significant IND risk factors. Elevated preoperative platelet and hemoglobin levels were associated with reduced IND risk.

Conclusions

This AI model provides precise IND prediction in CEA, enabling tailored interventions for high-risk patients and ultimately improving surgical outcomes. BMI, contralateral stenosis, and selected blood parameters emerged as pivotal predictors, bringing significant advancements to decision-making in CEA procedures. Further validation in larger cohorts is essential for broader clinical implementation.
目的:接受颈动脉内膜剥脱术(CEA)的患者中,约有8%可能在颈动脉交叉钳夹术中出现神经系统清醒试验阳性。本研究旨在评估人工智能(AI)驱动的风险计算器在预测术中神经功能缺损(IND)方面的准确性:方法:从2012年1月至2023年1月期间在区域麻醉下进行的颈动脉介入手术中收集数据。采用病例对照研究设计,选择 IND 患者和未发生 IND 的连续对照组。利用机器学习(ML),特别是极端梯度提升(XGBoost)模型,开发了IND预测模型,并对其性能进行了评估,并与现有的预测模型进行了比较。对模型的解释采用了 Shapley Additive exPlanations(SHAP)分析法:在 216 例患者中,108 例在 CEA 期间出现 IND。基于人工智能的预测模型的稳健曲线下面积(AUC)为 0.82,准确度为 0.75,精确度为 0.88,灵敏度为 0.59,F1Score 为 0.71。高体重指数(BMI)增加了对侧颈动脉狭窄,肢体瘫痪或截瘫病史是IND的重要风险因素。术前血小板和血红蛋白水平升高与 IND 风险降低有关:该人工智能模型可对 CEA 的 IND 进行精确预测,从而为高风险患者提供量身定制的干预措施,最终改善手术效果。体重指数、对侧血管狭窄程度和选定的血液参数是关键的预测因素,为CEA手术的决策带来了重大进步。在更大范围的临床应用中,进一步的队列验证至关重要。
{"title":"Predictive Factors Driving Positive Awake Test in Carotid Endarterectomy Using Machine Learning","authors":"Juliana Pereira-Macedo ,&nbsp;Ana Daniela Pias ,&nbsp;Luís Duarte-Gamas ,&nbsp;Piotr Myrcha ,&nbsp;José P. Andrade ,&nbsp;Nuno António ,&nbsp;Ana Marreiros ,&nbsp;João Rocha-Neves","doi":"10.1016/j.avsg.2024.10.011","DOIUrl":"10.1016/j.avsg.2024.10.011","url":null,"abstract":"<div><h3>Background</h3><div>Positive neurologic awake testing during the carotid cross-clamping may be present in around 8% of patients undergoing carotid endarterectomy (CEA). The present work aimed to assess the accuracy of an artificial intelligence (AI)-powered risk calculator in predicting intraoperative neurologic deficits (INDs).</div></div><div><h3>Methods</h3><div>Data was collected from carotid interventions performed between January 2012 and January 2023 under regional anesthesia. Patients with IND were selected along with consecutive controls without IND in a case-control study design. A predictive model for IND was developed using machine learning, specifically Extreme Gradient Boosting (XGBoost) model, and its performance was assessed and compared to an existing predictive model. Shapley Additive exPlanations (SHAP) analysis was employed for the model interpretation.</div></div><div><h3>Results</h3><div>Among 216 patients, 108 experienced IND during CEA. The AI-based predictive model achieved a robust area under the curve of 0.82, with an accuracy of 0.75, precision of 0.88, sensitivity of 0.59, and F1Score of 0.71. High body mass index (BMI) increased contralateral carotid stenosis, and a history of limb paresis or plegia were significant IND risk factors. Elevated preoperative platelet and hemoglobin levels were associated with reduced IND risk.</div></div><div><h3>Conclusions</h3><div>This AI model provides precise IND prediction in CEA, enabling tailored interventions for high-risk patients and ultimately improving surgical outcomes. BMI, contralateral stenosis, and selected blood parameters emerged as pivotal predictors, bringing significant advancements to decision-making in CEA procedures. Further validation in larger cohorts is essential for broader clinical implementation.</div></div>","PeriodicalId":8061,"journal":{"name":"Annals of vascular surgery","volume":"111 ","pages":"Pages 110-121"},"PeriodicalIF":1.4,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142695204","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Annals of vascular surgery
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1